SEC FORM 3

SEC FORM 3SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Samuel Ronen

(Last)

(First)

(Middle)

C/O KORNIT DIGITAL LTD., 12 HA'AMAL ST.

(Street)

ROSH-HA'AYIN

4809246

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Kornit Digital Ltd. [ KRNT ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Executive Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary shares	101,494	D
Ordinary shares⁽¹⁾	11,788	D
Ordinary shares⁽²⁾	13,095	D
Ordinary shares⁽³⁾	21,724	D
Ordinary shares⁽⁴⁾	39,967	D
Ordinary shares⁽⁵⁾	164,582	D
Ordinary shares⁽⁶⁾	32,302	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Options (right to buy ordinary shares)	⁽⁷⁾	08/22/2029	Ordinary shares	37,500	$28.15	D
Options (right to buy ordinary shares)	⁽⁸⁾	08/12/2030	Ordinary shares	10,350	$57.79	D
Options (right to buy ordinary shares)	⁽⁹⁾	08/12/2031	Ordinary shares	5,005	$122.19	D
Options (right to buy ordinary shares)	⁽¹⁰⁾	08/11/2032	Ordinary shares	23,775	$35.51	D
Options (right to buy ordinary shares)	⁽¹¹⁾	12/29/2032	Ordinary shares	23,158	$22.02	D
Options (right to buy ordinary shares)	⁽¹²⁾	08/12/2033	Ordinary shares	48,525	$23	D
Options (right to buy ordinary shares)	⁽¹³⁾	08/12/2034	Ordinary shares	65,036	$16.48	D
Options (right to buy ordinary shares)	⁽¹⁴⁾	08/12/2035	Ordinary shares	68,009	$15.19	D

Explanation of Responses:

1. The ordinary shares reported in this row consist of shares underlying restricted share units ("RSUs") that were granted to the Reporting Person on August 11, 2022 and that vest and settle for underlying ordinary shares in accordance with the following schedule: 25% of the RSUs vested and settled for underlying ordinary shares upon the one-year anniversary of the grant date, and an additional 6.25% of the RSUs vest and settle on a quarterly basis over the following three years such that all RSUs reported in this row will be fully vested and settled on the four-year anniversary of that grant date (August 11, 2026).

2. The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on December 29, 2022 and that vest and settle for underlying ordinary shares in accordance with the following schedule: 25% of the RSUs vested and settled for underlying ordinary shares upon the one-year anniversary of the grant date, and an additional 6.25% of the RSUs vest and settle on a quarterly basis over the following three years such that all RSUs reported in this row will be fully vested and settled on the four-year anniversary of that grant date (December 29, 2026).

3. The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on August 12, 2023 and that vest and settle for underlying ordinary shares in accordance with the following schedule: 25% of the RSUs vested and settled for underlying ordinary shares upon the one-year anniversary of the grant date, and an additional 6.25% of the RSUs vest and settle on a quarterly basis over the following three years such that all RSUs reported in this row will be fully vested and settled on the four-year anniversary of that grant date (August 12, 2027).

4. The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on August 12, 2024 and that vest and settle for underlying ordinary shares in accordance with the following schedule: 25% of the RSUs vested and settled for underlying ordinary shares upon the one-year anniversary of the grant date, and an additional 6.25% of the RSUs vest and settle on a quarterly basis over the following three years such that all RSUs reported in this row will be fully vested and settled on the four-year anniversary of that grant date (August 12, 2028).

5. The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on August 12, 2025 and that vest and settle for underlying ordinary shares in accordance with the following schedule: 25% of the RSUs will vest and settle for underlying ordinary shares upon the one-year anniversary of the grant date, and an additional 6.25% of the RSUs will vest and settle on a quarterly basis over the following three years such that all RSUs reported in this row will be fully vested and settled on the four-year anniversary of that grant date (August 12, 2029).

6. The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on August 12, 2025 and that vest and settle for underlying ordinary shares in accordance with the following schedule: 25% of the RSUs will vest and settle for underlying ordinary shares upon the one-year anniversary of the grant date, and an additional 6.25% of the RSUs will vest and settle on a quarterly basis over the following three years such that all RSUs reported in this row will be fully vested and settled on the four-year anniversary of that grant date (August 12, 2029).

7. All options to purchase ordinary shares reported in this row fully vested and became exercisable prior to the date of this report.

8. All options to purchase ordinary shares reported in this row fully vested and became exercisable prior to the date of this report.

9. All options to purchase ordinary shares reported in this row fully vested and became exercisable prior to the date of this report.

10. The options to purchase ordinary shares reported in this row were granted by the Issuer to the Reporting Person on August 11, 2022 and vest and become exercisable for underlying ordinary shares in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the grant date, and an additional 6.25% of the options vest on a quarterly basis over the following three years such that all options reported in this row will be fully vested and exercisable on the four-year anniversary of the grant date (August 11, 2026).

11. The options to purchase ordinary shares reported in this row were granted by the Issuer to the Reporting Person on December 29, 2022 and vest and become exercisable for underlying ordinary shares in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the grant date, and an additional 6.25% of the options vest on a quarterly basis over the following three years such that all options reported in this row will be fully vested and exercisable on the four-year anniversary of the grant date (December 29, 2026).

12. The options to purchase ordinary shares reported in this row were granted by the Issuer to the Reporting Person on August 12, 2023 and vest and become exercisable for underlying ordinary shares in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the grant date, and an additional 6.25% of the options vest on a quarterly basis over the following three years such that all options reported in this row will be fully vested and exercisable on the four-year anniversary of the grant date (August 12, 2027).

13. The options to purchase ordinary shares reported in this row were granted by the Issuer to the Reporting Person on August 12, 2024 and vest and become exercisable for underlying ordinary shares in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the grant date, and an additional 6.25% of the options vest on a quarterly basis over the following three years such that all options reported in this row will be fully vested and exercisable on the four-year anniversary of the grant date (August 12, 2028).

14. The options to purchase ordinary shares reported in this row were granted by the Issuer to the Reporting Person on August 12, 2025 and vest and become exercisable for underlying ordinary shares in accordance with the following schedule: 25% of the options will vest upon the one-year anniversary of the grant date, and an additional 6.25% of the options will vest on a quarterly basis over the following three years such that all options reported in this row will be fully vested and exercisable on the four-year anniversary of the grant date (August 12, 2029).

Remarks:

Exhibit 24.1 - Power of Attorney

	/s/ Assaf Zipori, attorney-in-fact	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

SEC Form 3 filed by new insider Samuel Ronen